| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 11/24/2005 | US20050260272 Method of forming microparticles that include a bisphosphonate and a polymer |
| 11/24/2005 | US20050260271 Composition comprising layered host material with intercalated functional-active organic compound |
| 11/24/2005 | US20050260270 Inhibition of gene expression by delivery of small interfering RNA to post-embryonic animal cells in vivo |
| 11/24/2005 | US20050260268 Methods and dosage forms for controlled delivery of alprazolam |
| 11/24/2005 | US20050260267 Tablets exhibiting reduced drug release variability |
| 11/24/2005 | US20050260266 Tooth whiteners; encapsulated by a polymer matrix |
| 11/24/2005 | US20050260265 Mesostructured silica/block copolymer monoliths as a controlled release device and methods of manufacture |
| 11/24/2005 | US20050260264 Dosage form for delivery of multiple drug forms |
| 11/24/2005 | US20050260263 Sustained release formulation for sparingly soluble main drugs |
| 11/24/2005 | US20050260262 Comprising risedronate, a chelating agent, and, means for effecting delayed release of the risedronate and the chelating agent in the small intestine; enteric coating |
| 11/24/2005 | US20050260261 Neutral-cationic lipid for nucleic acid and drug delivery |
| 11/24/2005 | US20050260260 Liposome compositions for the delivery of macromolecules |
| 11/24/2005 | US20050260259 Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
| 11/24/2005 | US20050260258 Use of vitelline protein B as a microencapsulating additive |
| 11/24/2005 | US20050260257 Prophylactic, therapeutic and industrial antioxidant compositions enhanced with stabilized atomic hydrogen/free electrons and methods to prepare and use such compositions |
| 11/24/2005 | US20050260256 Methods and apparatus for extrusion of vesicles at high pressure |
| 11/24/2005 | US20050260255 Adhesive patch |
| 11/24/2005 | US20050260254 Hot melt tts for administering rotigotine |
| 11/24/2005 | US20050260253 Transmucosal gel formulations |
| 11/24/2005 | US20050260252 Transdermal delivery system for anti-emetic medication |
| 11/24/2005 | US20050260247 Implantable prosthetic devices containing timed release therapeutic agents |
| 11/24/2005 | US20050260237 Delivery Agents for enhancing mucosal absorption of therapeutic agents |
| 11/24/2005 | US20050260236 Direct compression polymer tablet core |
| 11/24/2005 | US20050260228 Vaccines absorbable by the transmucosal way |
| 11/24/2005 | US20050260217 Co-encapsulated WT1 polypeptide and immunostimulant microsphere formulations and methods thereof |
| 11/24/2005 | US20050260208 Binding agents and their use in targeting tumor cells |
| 11/24/2005 | US20050260189 Microbubble compositions, and methods for preparing and using same |
| 11/24/2005 | US20050260185 Methods for treating diseases caused by deficiencies of recombinant alpha-L-iduronidase |
| 11/24/2005 | US20050260163 Triplex hairpin ribozyme |
| 11/24/2005 | US20050260145 Oil soluble compositions |
| 11/24/2005 | US20050260140 Mucolytic and anti-elastase compounds and methods of use thereof |
| 11/24/2005 | US20050260139 Pharmaceutical compositions based on anticholinergics and CCR2 receptor antagonists |
| 11/24/2005 | US20050260115 Method of preparing porous calcium phosphate granules |
| 11/24/2005 | US20050258288 High pressure media milling system and process of forming particles |
| 11/24/2005 | US20050258192 Method of producing foamed cleaser with suspended particles therein and a dispenser therefore |
| 11/24/2005 | DE202005014101U1 Pedicure- and wound care agents, useful in foot care, wound therapy and for prophylaxis of infection, comprises creams, cream foam, ointments, balm and interactive wound care oregano oil and/or oregano products |
| 11/24/2005 | DE102004021992A1 Topische Zubereitung enthaltend Ambroxol The topical preparation containing ambroxol |
| 11/24/2005 | DE102004021281A1 Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin Use of meloxicam formulations in veterinary medicine |
| 11/24/2005 | DE102004020721A1 Dermal applizierbare flüssige Formulierungen zur Bekämpfung von parasitierenden Insekten an Tieren Dermally applicable liquid formulations for controlling parasitic insects on animals |
| 11/24/2005 | DE102004019753A1 Antiinflammatory finishing of hygiene articles, e.g. diapers or tampons, to prevent inflammation on contact with skin, using phytosterols, especially from avocado oil non-saponifiable components |
| 11/24/2005 | CA2607206A1 Transdermal administration of phycotoxins |
| 11/24/2005 | CA2566837A1 Anti acne skincare composition and skincare article |
| 11/24/2005 | CA2566364A1 Hydrogel interferon formulations |
| 11/24/2005 | CA2566326A1 Peritoneal dialysis solution |
| 11/24/2005 | CA2566325A1 Film-shaped estriol-containing medicament for oral administration |
| 11/24/2005 | CA2566188A1 Use of targeted oxidative therapeutic formulation in bone regeneration |
| 11/24/2005 | CA2566185A1 Formulations with controlled release of active ingredient |
| 11/24/2005 | CA2565915A1 Inhalation powder formulations containing enantiomerically pure beta-agonists |
| 11/24/2005 | CA2565859A1 Pulmonary malarial vaccine |
| 11/24/2005 | CA2565612A1 Antimicrobial articles |
| 11/24/2005 | CA2565424A1 Macromolecule-containing sustained release intraocular implants and related methods |
| 11/24/2005 | CA2565347A1 Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies |
| 11/24/2005 | CA2565296A1 Sustained-release microspheres and methods of making and using same |
| 11/24/2005 | CA2565249A1 Intravitreal implants in conjunction with photodynamic therapy to improve vision |
| 11/24/2005 | CA2565239A1 Oil-in-water emulsion for delivery |
| 11/24/2005 | CA2565067A1 Intraocular implants of alpha-2 adrenergic receptor agonists and methods for improving vision |
| 11/24/2005 | CA2564948A1 An estradiol derivative or an estratopone derivative containing sustained release intraocular implant as well as related methods of manufacturing |
| 11/24/2005 | CA2563489A1 Topical methadone compositions and methods for using the same |
| 11/24/2005 | CA2562499A1 Nucleotide-cochleate compositions and methods of use |
| 11/24/2005 | CA2560981A1 Polymer-based sustained release device |
| 11/23/2005 | EP1598080A1 Seamless capsule |
| 11/23/2005 | EP1598074A1 Stabilized preparation containing protein |
| 11/23/2005 | EP1598072A1 Medical drug containing fine particle of noble metal |
| 11/23/2005 | EP1598071A1 Superoxide anion decomposing agent |
| 11/23/2005 | EP1598069A2 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| 11/23/2005 | EP1598066A1 Powder inhalant of sumatriptan and the method of preparation thereof |
| 11/23/2005 | EP1598062A1 Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
| 11/23/2005 | EP1598061A1 Intraorally rapidly disintegrable tablet |
| 11/23/2005 | EP1598060A1 Oil-in-water emulsion for delivery |
| 11/23/2005 | EP1598059A1 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
| 11/23/2005 | EP1598054A2 Method of suppressing appetite |
| 11/23/2005 | EP1598045A2 Stable water-in-oil emulsion system |
| 11/23/2005 | EP1597973A1 Oil-in-water emulsion for delivery |
| 11/23/2005 | EP1597318A1 Poloxamer emulsion preparations |
| 11/23/2005 | EP1597277A2 Hypoallergenic der p 1 and der p 3 proteins from dermatographoides pteronyssinus |
| 11/23/2005 | EP1597265A2 Glycosolated enkephalin agents |
| 11/23/2005 | EP1597171A2 Therapeutic microfoam |
| 11/23/2005 | EP1597048A2 Method of producing structures using centrifugal forces |
| 11/23/2005 | EP1596969A2 Method and apparatus for enhanced size reduction of particles |
| 11/23/2005 | EP1596962A2 Gas accumulator for storing a predetermined gas quantity and for releasing said gas for medical use |
| 11/23/2005 | EP1596895A2 Occlusion resistant hydrocephalic shunt |
| 11/23/2005 | EP1596876A1 Use of pvp-iodine liposomes for treatment of acne |
| 11/23/2005 | EP1596870A1 High dose ibandronate formulation |
| 11/23/2005 | EP1596863A2 Pharmaceutical compositions for nasal delivery |
| 11/23/2005 | EP1596849A1 Controlled release pharmaceutical compositions of tamsulosin |
| 11/23/2005 | EP1596842A2 Dermal, transdermal, mucosal or transmucosal ingredient delivery devices |
| 11/23/2005 | EP1596841A1 Therapeutic system comprising amoxicillin and clavulanic acid |
| 11/23/2005 | EP1596840A1 Use of p-glycoprotein inhibitor surfactants at the surface of a colloidal carrier |
| 11/23/2005 | EP1596839A2 Semi-solid immediate-release oral formulations comprising an anticancer hydrophobic agent, a polyglycolised glyceride and a hydrophilic carrier |
| 11/23/2005 | EP1596838A2 Once a day orally administered pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent |
| 11/23/2005 | EP1596837A2 Sustained release formulations of venlafaxine |
| 11/23/2005 | EP1596836A2 Sugar-free oral transmucosal solid dosage forms and uses thereof |
| 11/23/2005 | EP1596835A1 Method for preparation of an agglomerate using melt agglomeration |
| 11/23/2005 | EP1596834A2 Microparticles comprising polynucleotides adsorbed on the surface of or entrapped within the microparticles |
| 11/23/2005 | EP1596833A1 Particle formulation and its preparation |
| 11/23/2005 | EP1596832A2 Menthol solutions of drugs |
| 11/23/2005 | EP1596831A2 Material incapsulation system |
| 11/23/2005 | EP1596830A1 Novel fluticasone formulations |
| 11/23/2005 | EP1596829A2 Liposome composition for reduction of liposome-induced complement activation |
| 11/23/2005 | EP1596828A2 Lipophilic drug delivery vehicle and methods of use thereof |